Grants and Contributions:
Title:
Implementation of revised Strategic Plan for Ekosi Harm-and-Pharma Reduction Initiative
Agreement Number:
974069
Agreement Value:
$50,000.00
Agreement Date:
Jun 28, 2021 - Feb 18, 2022
Description:
This project is focused on continuing to expand the company’s suite of offerings to position it as a market leader in the delivery of services to enhance health and reduce dependence on pharmaceutical interventions. Specifically, a Strategic Plan for the company’s innovative Harm and Pharma Reduction Program is to be implemented as a result of this project.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Gimli, Manitoba, CA R0C 1B0
Reference Number:
172-2021-2022-Q2-974069
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
714721313
Recipient Type:
For-profit organization
Recipient's Operating Name:
Ekosi
Recipient's Legal Name:
Ekosi Health Centre Corp.
Federal Riding Name:
Selkirk--Interlake--Eastman
Federal Riding Number:
46010
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410